NAMPT and gastric cancer: Visfatin upregulated Snai1 by approximately 1.5-fold through the activation of the NF-κB signaling pathway, contributing to the epithelial–mesenchymal transition (EMT) process and facilitating the migration and invasion of gastric cancer cells [51].